KDM1A and non-small cell lung carcinoma: Overall, this study reveals a key target of KDM1A and a signaling pathway involving KDM1A-induced invasion and migration in NSCLC cells, and suggests that pharmacological inhibition of KDM1A may be used to treat NSCLC.